|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mazzaferri EL and Jhiang SM: Long-term
impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 97:418–428. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cornett WR, Sharma AK, Day TA, Richardson
MS, Hoda RS, van Heerden JA and Fernandes JK: Anaplastic thyroid
carcinoma: An Overview. Curr Oncol Rep. 9:152–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ain KB, Egorin MJ and DeSimone PA;
Collaborative Anaplastic Thyroid Cancer Health Intervention Trials
(CATCHIT) Group: Treatment of anaplastic thyroid carcinoma with
paclitaxel: Phase 2 trial using ninety-six-hour infusion. Thyroid.
10:587–594. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen B, Wang X, Zhao W and Wu J: Klotho
inhibits growth and promotes apoptosis in human lung cancer cell
line A549. J Exp Clin Cancer Res. 29:99–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen L, Liu H, Liu J, Zhu Y, Xu L, He H,
Zhang H, Wang S, Wu Q, Liu W, et al: Klotho endows hepatoma cells
with resistance to anoikis via VEGFR2/PAK1 activation in
hepatocellular carcinoma. PLoS One. 8:e584132013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiraki-Iida T, Aizawa H, Matsumura Y,
Sekine S, Iida A, Anazawa H, Nagai R, Kuro-o M and Nabeshima Y:
Structure of the mouse klotho gene and its two transcripts encoding
membrane and secreted protein. FEBS Lett. 424:6–10. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wolf I, Levanon-Cohen S, Bose S, Ligumsky
H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP,
et al: Klotho: A tumor suppressor and a modulator of the IGF-1 and
FGF pathways in human breast cancer. Oncogene. 27:7094–7105. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi
H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et
al: Mutation of the mouse klotho gene leads to a syndrome
resembling ageing. Nature. 390:45–51. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsumura Y, Aizawa H, Shiraki-Iida T,
Nagai R, Kuro-o M and Nabeshima Y: Identification of the human
klotho gene and its two transcripts encoding membrane and secreted
klotho protein. Biochem Biophys Res Commun. 242:626–630. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nagai T, Yamada K, Kim HC, Kim YS, Noda Y,
Imura A, Nabeshima Y and Nabeshima T: Cognition impairment in the
genetic model of aging klotho gene mutant mice: A role of oxidative
stress. FASEB J. 17:50–52. 2003.
|
|
13
|
Nagai R, Saito Y, Ohyama Y, Aizawa H, Suga
T, Nakamura T, Kurabayashi M and Kuroo M: Endothelial dysfunction
in the klotho mouse and downregulation of klotho gene expression in
various animal models of vascular and metabolic diseases. Cell Mol
Life Sci. 57:738–746. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saito Y, Yamagishi T, Nakamura T, Ohyama
Y, Aizawa H, Suga T, Matsumura Y, Masuda H, Kurabayashi M, Kuro-o
M, et al: Klotho protein protects against endothelial dysfunction.
Biochem Biophys Res Commun. 248:324–329. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arking DE, Krebsova A, Macek M Sr, Macek M
Jr, Arking A, Mian IS, Fried L, Hamosh A, Dey S, McIntosh I, et al:
Association of human aging with a functional variant of klotho.
Proc Natl Acad Sci USA. 99:856–861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao Y, Pinzi V, Bourhis J and Deutsch E:
Mechanisms of disease: Signaling of the insulin-like growth factor
1 receptor pathway - therapeutic perspectives in cancer. Nat Clin
Pract Oncol. 4:591–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mattarocci S, Abbruzzese C, Mileo AM,
Visca P, Antoniani B, Alessandrini G, Facciolo F, Felsani A,
Radulescu RT and Paggi MG: Intracellular presence of insulin and
its phosphor-ylated receptor in non-small cell lung cancer. J Cell
Physiol. 221:766–770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang B, Kim J, Jeong D, Jeong Y, Jeon S,
Jung SI, Yang Y, Kim KI, Lim JS, Kim C, et al: Klotho inhibits the
capacity of cell migration and invasion in cervical cancer. Oncol
Rep. 28:1022–1028. 2012.PubMed/NCBI
|
|
19
|
Yahata K, Mori K, Mukoyama M, Sugawara A,
Suganami T, Makino H, Nagae T, Fujinaga Y, Nabeshima Y and Nakao K:
Regulation of stanniocalcin 1 and 2 expression in the kidney by
klotho gene. Biochem Biophys Res Commun. 310:128–134. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang AC, Jeffrey KJ, Tokutake Y,
Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y
and Reddel RR: Human stanniocalcin (STC): Genomic structure,
chromosomal localization, and the presence of CAg trinucleotide
repeats. Genomics. 47:393–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wagner GF, Hampong M, Park CM and Copp DH:
Purification, characterization, and bioassay of teleocalcin, a
glycoprotein from salmon corpuscles of Stannius. Gen Comp
Endocrinol. 63:481–491. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayase S, Sasaki Y, Matsubara T, Seo D,
Miyakoshi M, Murata T, Ozaki T, Kakudo K, Kumamoto K, Ylaya K, et
al: Expression of stanniocalcin 1 in thyroid side population cells
and thyroid cancer cells. Thyroid. 25:425–436. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeung BH, Law AY and Wong CK: Evolution
and roles of stanniocalcin. Mol Cell Endocrinol. 349:272–280. 2012.
View Article : Google Scholar
|
|
24
|
Varghese R, Wong CK, Deol H, Wagner GF and
DiMattia GE: Comparative analysis of mammalian stanniocalcin genes.
Endocrinology. 139:4714–4725. 1998.PubMed/NCBI
|
|
25
|
Chang AC, Janosi J, Hulsbeek M, de Jong D,
Jeffrey KJ, Noble JR and Reddel RR: A novel human cDNA highly
homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol.
112:241–247. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang AC, Jellinek DA and Reddel RR:
Mammalian stanniocalcins and cancer. Endocr Relat Cancer.
10:359–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujiwara Y, Sugita Y, Nakamori S, Miyamoto
A, Shiozaki K, Nagano H, Sakon M and Monden M: Assessment of
stannio-calcin-1 mRNA as a molecular marker for micrometastases of
various human cancers. Int J Oncol. 16:799–804. 2000.PubMed/NCBI
|
|
28
|
McCudden CR, Majewski A, Chakrabarti S and
Wagner GF: Co-localization of stanniocalcin-1 ligand and receptor
in human breast carcinomas. Mol Cell Endocrinol. 213:167–172. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okabe H, Satoh S, Kato T, Kitahara O,
Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y:
Genome-wide analysis of gene expression in human hepatocellular
carcinomas using cDNA microarray: Identification of genes involved
in viral carcinogenesis and tumor progression. Cancer Res.
61:2129–2137. 2001.PubMed/NCBI
|
|
30
|
Chen B, Ma X, Liu S, Zhao W and Wu J:
Inhibition of lung cancer cells growth, motility and induction of
apoptosis by Klotho, a novel secreted Wnt antagonist, in a
dose-dependent manner. Cancer Biol Ther. 13:1221–1228. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shih A, Davis FB, Lin HY and Davis PJ:
Resveratrol induces apoptosis in thyroid cancer cell lines via a
MAPK- and p53-dependent mechanism. J Clin endocrinol Metab.
87:1223–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
33
|
Liu G, Yang G, Chang B, Mercado-Uribe I,
Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and
ovarian tumorigenesis. J Natl Cancer Inst. 102:812–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Abramovitz L, Rubinek T, Ligumsky H, Bose
S, Barshack I, Avivi C, Kaufman B and Wolf I: KL1 internal repeat
mediates klotho tumor suppressor activities and inhibits bFGF and
IGF-I signaling in pancreatic cancer. Clin Cancer Res.
17:4254–4266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen CD, Podvin S, Gillespie E, Leeman SE
and Abraham CR: Insulin stimulates the cleavage and release of the
extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad
Sci USA. 104:19796–19801. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee J, Jeong DJ, Kim J, Lee S, Park JH,
Chang B, Jung SI, Yi L, Han Y, Yang Y, et al: The anti-aging gene
KLOTHO is a novel target for epigenetic silencing in human cervical
carcinoma. Mol Cancer. 9:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Wang X, Wang X, Jie P, Lu H, Zhang
S, Lin X, Lam EK, Cui Y, Yu J, et al: Klotho is silenced through
promoter hypermethylation in gastric cancer. Am J Cancer Res.
1:111–119. 2011.PubMed/NCBI
|
|
38
|
Pan J, Zhong J, Gan LH, Chen SJ, Jin HC,
Wang X and Wang LJ: Klotho, an anti-senescence related gene, is
frequently inactivated through promoter hypermethylation in
colorectal cancer. Tumour Biol. 32:729–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu H, Fergusson MM, Castilho RM, Liu J,
Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, et al:
Augmented Wnt signaling in a mammalian model of accelerated aging.
Science. 317:803–806. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yeung HY, Lai KP, Chan HY, Mak NK, Wagner
GF and Wong CK: Hypoxia-inducible factor-1-mediated activation of
stanniocalcin-1 in human cancer cells. Endocrinology.
146:4951–4960. 2005. View Article : Google Scholar : PubMed/NCBI
|
